- Home
- WST vs MTZ Comparison
WST vs MTZ Comparison
Compare WST & MTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WST | MTZ |
|---|---|---|
| Founded | 1923 | 1929 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Water Sewer Pipeline Comm & Power Line Construction |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.2B | 17.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WST | MTZ |
|---|---|---|
| Price | $273.92 | $225.47 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 20 |
| Target Price | ★ $345.75 | $231.37 |
| AVG Volume (30 Days) | 675.4K | ★ 756.3K |
| Earning Date | 02-12-2026 | 10-30-2025 |
| Dividend Yield | ★ 0.32% | N/A |
| EPS Growth | 0.17 | ★ 270.77 |
| EPS | ★ 6.75 | 4.20 |
| Revenue | $3,017,900,000.00 | ★ $13,762,473,000.00 |
| Revenue This Year | $7.01 | $15.48 |
| Revenue Next Year | $6.20 | $10.21 |
| P/E Ratio | ★ $40.75 | $51.78 |
| Revenue Growth | 4.92 | ★ 12.99 |
| 52 Week Low | $187.43 | $99.70 |
| 52 Week High | $348.90 | $233.14 |
Technical Indicators
Market Signals| Indicator | WST | MTZ |
|---|---|---|
| Relative Strength Index (RSI) | 51.05 | 59.19 |
| Support Level | $272.53 | $216.68 |
| Resistance Level | $277.75 | $225.50 |
| Average True Range (ATR) | 5.70 | 6.56 |
| MACD | 0.39 | -0.43 |
| Stochastic Oscillator | 65.51 | 77.92 |
Price Performance
Historical ComparisonAbout WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About MTZ MasTec Inc.
MasTec is a leading infrastructure construction company operating mainly in North America across a range of industries. Its primary activities include engineering, building, installing, maintaining, and upgrading communications, oil and gas, utility, renewable energy, and other infrastructure. MasTec reports its results under five segments: communications; clean energy and infrastructure; oil and gas; power delivery; and other.